Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years

This study is not yet open for participant recruitment.
Verified November 2012 by Prostrakan Pharmaceuticals
Sponsor:
Information provided by (Responsible Party):
Prostrakan Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01596413
First received: April 26, 2012
Last updated: November 29, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)